CytoCore (MDIT) Stock Price, News & Analysis

Company Overview

CytoCore, Inc. is a biotechnology company associated with the OTC Markets symbol MDIT. Publicly available information describes the company as being focused on diagnostic technologies, with an emphasis on cytology and cancer-related testing.

The company’s activities have included the development of tools and services intended to support the detection and evaluation of disease through laboratory-based diagnostic methods. Specific commercial products, operating geographies and current business activities are not clearly documented in reliable public sources.

Detailed information about CytoCore’s current leadership, corporate history and market presence is also limited. Investors should consult the company’s latest public disclosures and regulatory filings for the most up-to-date information.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 30 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/31/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:MDIT
• CIK: 75439
• Web: www.cytocoreinc.com
• Phone: (407) 996-9630
• Fax: 407-996-9631
• Employees: 71
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 111.68